Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective for this study will be to assess the proportion of subjects with a new clinical flare of SLE (BILAG “A” or “B”) during the 1 year double-blind treatment period, comparing abatacept with placebo on a background of tapering glucocorticosteroids.
Critère d'inclusion
- Systemic lupus erythematosus NOS